Zakaria, N.; Wendon, J.; Devlin, J.
April 2003
Gut;Apr2003 Supplement 1, Vol. 52, pA35
Academic Journal
Background and Aims: Antiphospholipid syndrome (APS) is increasingly recognised to have a wide range of clinical manifestations, although involvement from this disorder within the liver or its vasculature is poorly identified. Patients and Methods: 49 consecutive patients with a liver disorder investigated between 1994 and 2002 who fulfilled the diagnostic criteria for APS were studied. Patients were followed up for a median of 10 months (range 6-94 months). Results: Of the 49 cases, 21 were male, 28 female. Median age at presentation was 42 (range 17-67). 29 patients were north European (60%), 5 (10%) Mediterranean, 8 (16%) Afro-Caribbean, and 7 (14%) Asian. 36 patients had primary APS (80%), 7 had APS associated with SLE (14%) and 3 associated with other autoimmune diseases (6%). 3 patients had "equivocal" APS. A diagnosis of APS had been made in only 2 of 49 (4%) symptomatic cases prior to referral. A wide range of clinical and pathological findings involving the liver parenchyma and its vascular compartments were identified. 6 (12%) had either thrombosis or arteritis of the hepatic arterial tree. Porto-mesenteric thrombosis was present in 13 cases (27%) and nodular regenerative hyperplasia in 7 (14%). In 9 patients, Budd Chiari syndrome (6), veno-occlusive disease (2) or congestion secondary to right ventricular failure (1) was diagnosed. Autoimmune hepatitis was diagnosed in 9 patients. Associated non-hepatic clinical manifestations included vasculitis (10 (20%)), thromboses (8 (16%)) and unexplained myocardial dysfunction (5 (10%)). Anticardiolipin antibodies were detected in 48 of 49 (98%) and Lupus anticoagulant in 14 of 36 (39%) of the patients tested. Complement C4 levels were Iow in 22 of 33 (67%) patients tested. 7 of 49 (14%) had SLE. 11 underwent transplantation for APS related liver disease (Budd-Chiari syndrome 3, hepatic artery thrombosis 3, NRH 3, autoimmune hepatitis 1, veno-occlusive disease 1). 4 of the 49 patients died. Conclusion: The...


Related Articles

  • Recent data help diagnose, manage collagen vascular disease. McCann, Brian // Dermatology Times;Aug98, Vol. 19 Issue 8, p53 

    Focuses on the changes that occur in the working knowledge of collagen vascular diseases. Lists of drugs that induce subacute cutaneous lupus erythematosus (SCLE); Most important cutaneous manifestations of antiphospholipid syndrome; Information on retinal toxicity resulting from the use of...

  • Central retinal vein occlusion and thrombophilia. Fegan, C.D. // Eye;Jan2002, Vol. 16 Issue 1, p98 

    Central retinal vein occlusion is one of the commonest vascular diseases of the eye. The pathogenesis is multifactorial with both local factors and systemic diseases being aetiologically important. Many thrombophilic conditions have recently been identified and studies looking at their potential...

  • Vasculitis.  // Current Medical Literature: Rheumatology;2006, Vol. 25 Issue 2, p49 

    Discusses several research on vasculitis published in medical journals in 2005 and 2006. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis; Prevalence of the antiphospholipid syndrome in primary systematic vasculitis; Use of...

  • Flow-Mediated Arterial Dilation in Primary Antiphospholipid Syndrome. Bilora, Franca; Sartori, Maria Teresa; Zanon, Ezio; Campagnolo, Enrico; Arzenton, Marianna; Rossato, Alberto // Angiology;Feb/Mar2009, Vol. 60 Issue 1, p104 

    Objective. To investigate precocious alterations in the artery wall of patients with primary antiphospholipid syndrome (APS). Methods. We evaluated flow-mediated dilation (FMD) of the brachial artery and intima-media thickness (IMT) of carotid arteries in 16 patients and 16 healthy controls...

  • Vascular Doppler: Bilateral stenosis of the internal carotid arteries. Arsenescu, Ileana // Romanian Journal of Cardiology;2012, Vol. 22 Issue 4, p330 

    The article discusses subclinical and clinical vascular abnormalities in patients with antiphospholipid syndrome (APS) and the role of cardiologists in the diagnosis of the condition. It explores the condition of therapy in patients with atherosclerosis and APS. It emphasizes the need for a...

  • Vascular disease in patients with antiphospholipid syndrome: what do the cardiologists need to know? Caraiola, Simona; Jurcut, C.; Jurcut, Ruxandra; Tanasescu, C. // Romanian Journal of Cardiology;2012, Vol. 22 Issue 4, p310 

    Antiphospholipid syndrome (APS) is a clinical and laboratory condition associating arterial or venous thrombosis, obstetrical morbidity and positive antiphospholipid antibodies (aPL). A broad spectrum of cardiovascular manifestations was reported in patients with APS, focused mainly on...

  • Thromboembolic events after endovascular treatment of unruptured intracranial aneurysms in two patients with antiphospholipid-antibody syndrome. Pierot, L. // Neuroradiology;Mar2003, Vol. 45 Issue 3, p193 

    The article focuses on the thromboembolic events after endovascular treatment of unruptured intracranial aneurysms in two patients with antiphospholipid-antibody syndrome. It has been stated that the choice between surgical and endovascular treatment in patients with ruptured aneurysms has to be...

  • Cerebral haemostasis and antiphospholipid antibodies. Connor, P.; Hunt, B. J. // Lupus;2003, Vol. 12 Issue 12, p929 

    One of the major clinical concerns of the antiphospholipid syndrome (APS) is the propensity of antiphospholipid (aPL) antibodies to cause thrombosis in both the large and small vessels of the brain. In this article, we review the current understanding of haemostasis in cerebral circulation and...

  • Poster Presentations.  // Lupus;Jun2010 Supplement 1, Vol. 19 Issue S1, p44 

    The article presents abstracts on medical topics which include a research linking hyperferritinemia with serologic antiphospholipid syndrome in systemic lupus erythematosus (SLE) patients, a study which correlates hyperprolactinemia with anemia and proteinuria and may predict serositis in SLE...


Read the Article


Sign out of this library

Other Topics